86.22.Z - Specialist medical practice activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
85.5 - Other education
85.6 - Educational support activities
86.1 - Hospital activities
86.2 - Medical and dental practice activities
86.90 - Other human health activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | 0,2 | 0,2 | 1,5 |
EBITDA | 0 | 0,3 | 0,3 | -0,6 |
Short time liabilities | 0,2 | 0,3 | 0,4 | 48,6 |
Equity capital | 0,3 | 0,5 | 0,7 | 46,8 |
Operating profit (EBIT) | -0 | 0,2 | 0,2 | 0,9 |
Assets | 0,5 | 0,9 | 1,1 | 31,2 |
Net profit (loss) | -0 | 0,2 | 0,2 | 2 |
Cash | 0,2 | 0,2 | 0,2 | 20 |
Net income from sale | 1,8 | 1,8 | 2,2 | 20 |
Liabilities and provisions for liabilities | 0,3 | 0,4 | 0,5 | 14,3 |
Working assets | 0,4 | 0,7 | 1 | 39,5 |
Depreciation | 0 | 0 | 0 | -8,8 |
% | % | % | p.p. | |
Profitability of capital | -3,8 | 45,9 | 31,9 | -14 |
Equity capital to total assets | 51 | 52 | 58,2 | 6,2 |
Gross profit margin | -0,5 | 12,1 | 10,3 | -1,8 |
EBITDA Margin | 2,1 | 14,3 | 11,9 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 43 | 56 | 69 | 13 |
Current financial liquidity indicator | 1.668077826499939 | 2.626133441925049 | 2.250882625579834 | -0,3 |
Net dept to EBITDA | -3.1002748012542725 | -0.06736768037080765 | -0.5845479965209961 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane